Comparison of simultaneous administration of lithium with L-NAME or L-arginine on morphine withdrawal syndrome in mice

Human Psychopharmacology

Volumn 15, Issue 2, 2000, Pages 87-93

  Dehpour, A R ^a   Sadr, S Sh ^a   Nouroddini, M ^a   Shadan, F ^a   Nourozi, A ^a   Farahani, M ^a   Sahebgharani, M ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

L arginine; L NAME; Lithium; Morphine dependence; Nitric oxide; Withdrawal syndrome

Indexed keywords

ARGININE; LITHIUM; MORPHINE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG ANTAGONISM; DRUG POTENTIATION; DRUG WITHDRAWAL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

EID: 0034038919     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(200003)15:2<87::AID-HUP147>3.0.CO;2-8     Document Type: Article

References (38)

1. Amir, S. and Simantov, R. (1981). Chronic lithium administration alters the interaction between opiate antagonists and opiate receptors in vivo. Neuropharmacology, 20, 587-591.
2. Babey, A. M., Kolesnicov, Y., Cheng, J., Inturrisi, C. E., Trifilletti, R. R. and Pasternak, G. W. (1994). Nitric oxide and opioid tolerance. Neuropharmacology, 33, 1463-1470.
3. Bagetta, G., Crasaniti, M. T., Melino, G., Paoletti, A. M., Finazzi, A. and Nistico, G. (1993). Lithium and facrine increase the expression of NOS mRNA in hippocampus of rat. Biochem. Biophys. Res. Commun., 197, 1132-1190.
4. Berridge, M. J. (1984). Inositol triphosphate and diasylglycerol as second messengers. Biochem. J., 220, 345-360.
5. Berridge, M. J., Downes, C. P. and Henley, M. R. (1982). Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem. J., 206, 587-595.
6. Bongianni, F., Carla, V., Moroni, F. and Pellegrini-Giampietro, D. E. (1986). Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats. British Journal of Pharmacology, 88, 561-567.
7. Buccafusco, J. J., Terry, A. V. and Shuster, L. (1995). Spinal NMDA receptor nitric oxide mediation of expression on morphine withdrawal symptoms in the rat. Brain Research, 679, 198-199.
8. Cappendijk, S. L. T., Duval, S. Y., Devries, R. and Dzoljic, M. R. (1994). Comparative study of normotensive and hypertensive nitric oxide synthase inhibitors on morphine withdrawal syndrome in rats. Neuroscience Letters, 183, 67-70.
9. Collier, H. O. J., Francis, D. L., Henderson, G. and Schneider, C. (1974). Quasi morphine abstinence syndrome. Nature, 249, 471-473.
10. Dehpour, A. R., Farsam, H. and Azizabadi-Farahani, M. (1995). Inhibition of morphine withdrawal syndrome and the development of physical dependence by lithium in mice. Neuropharmacology, 34, 115-121.
11. Drummond, A. H. (1987). Lithium and inositol lipid-linked signalling mechanisms. Trends Pharmac. Sci., 8, 129-133.
12. Dziedzicka, M., Kley, N., Lason, W. and Przewlocki, R. (1990). Adaptive changes in proenkephaline system upon the chronic presence of lithium. In New Leads in Opioid Research, Vanree, J. M., Mulder, A. H., Wiegant, V. M. and Griedanus, TBVW (Eds), Elsevier Science, Amsterdam, pp. 345-355.
13. Ebstein, R. P., Belmaker, R., Grunhaus, L. and Rimon, R. (1976). Lithium inhibition of adrenaline-stimulated adenylate cyclase in humans. Nature, 259, 411-413.
14. Ebstein, R. P., Hermoni, M. and Belmaker, R. H. (1980). The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain: inhibition after chronic treatment and absence of supersensitivity. J. Pharmacol. Exp. Ther., 213, 161-167.
15. 5] Enkephalin content in brain region of rats treated with lithium. Proceedings of the National Academy of Sciences of the USA, 75, 2991-2993.
16. Joseph, N. E., Renshaw, P. F. and Leigh, J. S. Jr (1987). Systemic lithium administration alters rat cerebral cortex phospholipids. Biol. Psychiat., 22, 546-544.
17. G-nitro-L-arginine prevents morphine tolerance. European Journal of Pharmacology, 221, 399-400.
18. Lonart, G., Wang, J. and Johnson, K. M. (1992). Nitric oxide induces neurotransmitter release from hippocampal slices. European Journal of Pharmacology, 220, 271-272.
19. 3H]dopamine release from striatal slices. Journal of Neuroscience Research, 35, 192-198.
20. Majeed, N. H., Przewlocka, B., Machelska, H. and Przewlocki, R. (1993). Inhibition of nitric oxixe synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology, 33, 189-192.
21. Mork, A. and Geister, A. (1987). Effects of lithium on calmodulin-stimulated adenylate cyclase activity in cortical membranes from rat brain. Pharmacol. Toxic., 60, 17-23.
22. Mork, A. and Geister, A. (1989). The effects of lithium in vitro and ex vivo on adenylate cyclase in brain are exerted by distinct mechanisms. Neuropharmacology, 28, 307-311.
23. Nahorski, S. R., Ragan, C. I. and Challis, R. A. J. (1991). Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences. Trends Pharmacol. Sci., 12, 297-303.
24. Newman, M., Klein, E., Birmaher, B., Feisod, M. and Belmaker, R. H. (1983). Lithium at therapeutic concentration inhibits human brain noradrenaline-sensitive cyclic AMP accumulation. Brain Research, 278, 380-381.
25. Newman, M. E. and Belmaker, R. H. (1987). Effects of lithium in vitro and ex vivo on components of the adenylate cyclase system in membranes from the cerebral cortex of the rat. Neuropharmacology, 26, 211-217.
26. Palmer, G. C., Robinson, G. A., Manian, A. A. and Sulser, F. (1972). Modification by psychotropic drugs of the cyclic AMP response to norepinephrine in the rat brain in vitro. Psychopharmacologia, 23, 201-211.
27. Prein, R. F., Kupfer, D. J., Mansky, P. A., Small, J. G., Tuason, V. B., Voss, C. B. and Johnson, W. E. (1984). Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative study group comparing lithium carbonate, imipramine and a lithium carbonate-imipramine combination. Archives of General Psychiatry, 41, 1096-1104.
28. Prast, H. and Philippu, A. (1992). Nitric oxide releases acetylcholine in the basal forebrain. Eur. J. Pharmacol., 316, 139-140.
29. Sabol, S. L., Yoshikawa, K. and Hong, J. S. (1983). Regulation of metionine-enkephalin precursor messenger RNA in rat striatum by haloperidol and lithium. Biochem. Biophys. Res. Commun., 113, 391-399.
30. Schon, M. (1968). Lithium in psychiatric therapy and prophylaxis. Journal of Psychiatric Research, 6, 67-95.
31. Sivam, S. P., Strunk, C., Smith, D. R. and Hong, J. S. (1986). Proenkephalin-A gene regulation in the rat striatum: influence of lithium and haloperidol. Molecular Pharmacology, 30, 186-191.
32. Sivam, S. P., Smith, D. R., Takeuchi, K. and Hong, J. S. (1987). Lithium and haloperidol differentially alter the dynorphin A(1-8) and enkephalin levels in neurointermediate lobe of rat pituitary. Neuropeptides, 10, 291-298.
33. Staunton, D. A., Dego, S. N., Shoemaker, W. J., Ettnberg, A. and Bloom, F. E. (1982). Effects of chronic lithium on enkephalin systems and pain responsiveness. Life Science, 31, 1837-1840.
34. Stengaard, P. K. and Schou, M. (1982). In vitro and in vivo inhibition by lithium of enkephalin binding to opiate receptor in rat brain. Neuropharmacology, 21, 817-823.
35. Stengaard, P. N. K. and Schou, M. (1985). Opioid peptides and receptors in relation to affective illness. Effects of desipramine and lithium on opioid receptors in rat brain. Acta Pharmacol. Toxicol., 56(Suppl.), 170-179.
36. Wajda, I. J., Banay, S. M., Manigault, I. and Lajtha, A. (1981). Effect of lithium and sodium ions on opiate-and dopamine-receptor binding. Neurochemistry Research, 6, 321-331.
37. Walker, J. B. (1974). The effect of lithium on hormone-sensitive adenylate cyclase from various regions of the rat brain. Biol. Psychiat., 8, 245-251.
38. Yoshikawa, K. and Hong, J. S. (1983). The enkephalin system in the rat anterior pituitary: regulation by gonadal steroid hormones and psychotropic drugs. Endocrinology, 113, 1218-1227.